Page last updated: 2024-12-08
di-tert-butyldiaziridinone
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
di-tert-butyldiaziridinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 545793 |
SCHEMBL ID | 7463539 |
MeSH ID | M0519556 |
Synonyms (15)
Synonym |
---|
1,2-ditert-butyldiaziridin-3-one |
diaziridinone, di-tert-butyl- |
1,2-ditert-butyl-[1,2]diaziridin-3-one |
1,2-DITERT-BUTYL-3-DIAZIRIDINONE |
di-tert-butyldiaziridinone |
WCHLJTGWJIJZMR-UHFFFAOYSA-N |
1,2-ditert-butyl-3-diaziridinone # |
diaziridinone, bis(1,1-dimethylethyl)-, trans- |
diaziridinone, bis(1,1-dimethylethyl)- |
di-t-butyldiaziridinone |
SCHEMBL7463539 |
19656-74-7 |
1,2-di-tert-butyldiaziridin-3-one |
DTXSID60337985 |
1,2-di-tert-butyl-3h-diazirine-3-one |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.11
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.11) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |